NCT02137668View on ClinicalTrials.gov

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

May 31, 2018

Study Completion Date

July 31, 2028

Conditions
Primary Sclerosing CholangitisBiliary Atresia
Interventions
DRUG

Oral Vancomycin

Oral Vancomycin is given to PSC or BA participants

Trial Locations (1)

95841

RECRUITING

Sacramento Pediatric Gastroenterology, Sacramento

All Listed Sponsors
lead

Sacramento Pediatric Gastroenterology

OTHER